| . | Oocyte donations (n = 423) . | Autologous PGT-A (n = 185) . | Total (n = 608) . |
|---|---|---|---|
| Culture strategy (%) | |||
| CS1 | 213 (50.4) | 0 (0) | 213 (35) |
| CS2 | 210 (49.6) | 185 (100) | 395 (65) |
| Oocyte provider age (years) | 25.5 ± 4.5 | 39.0 ± 3.4 | 29.6 ± 7.4 |
| Partner age (years) | 42.5 ± 6.4 | 40.4 ± 5.7 | 41.8 ± 6.3 |
| Oocyte provider BMI (kg/m2) | 22.6 ± 3.2 | 23.5 ± 3.8 | 22.9 ± 3.4 |
| Oocyte state | |||
| Fresh | 289 (68.3) | 181 (97.8) | 470 (77.3) |
| Vitrified | 134 (31.7) | 4 (2.2) | 138 (22.7) |
| Days of stimulation (days) | 10.3 ± 1.5 | 11.1 ± 1.7 | 10.6 ± 1.6 |
| Total gonadotropin dose (IU) | 2152.2 ± 681.3 | 3242.4 ± 1359.9 | 2483.9 ± 1065.5 |
| Sperm provider | |||
| Partner | 368 (87) | 161 (87) | 529 (87) |
| Donor | 55 (13) | 24 (13) | 79 (13) |
| Retrieved oocytes (n) | 23.9 ± 11.8 | 11.7 ± 6.0 | 20.2 ± 11.8 |
| MII oocytes injected (n) | 11.4 ± 2.8 | 9.3 ± 4.9 | 10.8 ± 3.7 |
| Fertilized oocytes (n) | 8.9 ± 2.6 | 7.0 ± 4.0 | 8.3 ± 3.2 |
| Fertilization rate (%) | 79.5 ± 14.3 | 78.1 ± 17.7 | 79.1 ± 15.4 |
| Blastocysts (n) | 6.2 ± 2.4 | 4.2 ± 2.8 | 5.6 ± 2.9 |
| Blastocyst rate (%) | 71.2 ± 20.9 | 59.8 ± 26.8 | 68.2 ± 23.2 |
| . | Oocyte donations (n = 423) . | Autologous PGT-A (n = 185) . | Total (n = 608) . |
|---|---|---|---|
| Culture strategy (%) | |||
| CS1 | 213 (50.4) | 0 (0) | 213 (35) |
| CS2 | 210 (49.6) | 185 (100) | 395 (65) |
| Oocyte provider age (years) | 25.5 ± 4.5 | 39.0 ± 3.4 | 29.6 ± 7.4 |
| Partner age (years) | 42.5 ± 6.4 | 40.4 ± 5.7 | 41.8 ± 6.3 |
| Oocyte provider BMI (kg/m2) | 22.6 ± 3.2 | 23.5 ± 3.8 | 22.9 ± 3.4 |
| Oocyte state | |||
| Fresh | 289 (68.3) | 181 (97.8) | 470 (77.3) |
| Vitrified | 134 (31.7) | 4 (2.2) | 138 (22.7) |
| Days of stimulation (days) | 10.3 ± 1.5 | 11.1 ± 1.7 | 10.6 ± 1.6 |
| Total gonadotropin dose (IU) | 2152.2 ± 681.3 | 3242.4 ± 1359.9 | 2483.9 ± 1065.5 |
| Sperm provider | |||
| Partner | 368 (87) | 161 (87) | 529 (87) |
| Donor | 55 (13) | 24 (13) | 79 (13) |
| Retrieved oocytes (n) | 23.9 ± 11.8 | 11.7 ± 6.0 | 20.2 ± 11.8 |
| MII oocytes injected (n) | 11.4 ± 2.8 | 9.3 ± 4.9 | 10.8 ± 3.7 |
| Fertilized oocytes (n) | 8.9 ± 2.6 | 7.0 ± 4.0 | 8.3 ± 3.2 |
| Fertilization rate (%) | 79.5 ± 14.3 | 78.1 ± 17.7 | 79.1 ± 15.4 |
| Blastocysts (n) | 6.2 ± 2.4 | 4.2 ± 2.8 | 5.6 ± 2.9 |
| Blastocyst rate (%) | 71.2 ± 20.9 | 59.8 ± 26.8 | 68.2 ± 23.2 |
CS1, culture strategy 1: Sanyo MCO-5M incubator and sequential culture media and Eeva Test 2.3; CS2, culture strategy 2: Geri+ and single-step culture medium and Eeva Test 3.0; MII: metaphase II oocyte; PGT-A: preimplantation genetic testing for aneuploidies.
| . | Oocyte donations (n = 423) . | Autologous PGT-A (n = 185) . | Total (n = 608) . |
|---|---|---|---|
| Culture strategy (%) | |||
| CS1 | 213 (50.4) | 0 (0) | 213 (35) |
| CS2 | 210 (49.6) | 185 (100) | 395 (65) |
| Oocyte provider age (years) | 25.5 ± 4.5 | 39.0 ± 3.4 | 29.6 ± 7.4 |
| Partner age (years) | 42.5 ± 6.4 | 40.4 ± 5.7 | 41.8 ± 6.3 |
| Oocyte provider BMI (kg/m2) | 22.6 ± 3.2 | 23.5 ± 3.8 | 22.9 ± 3.4 |
| Oocyte state | |||
| Fresh | 289 (68.3) | 181 (97.8) | 470 (77.3) |
| Vitrified | 134 (31.7) | 4 (2.2) | 138 (22.7) |
| Days of stimulation (days) | 10.3 ± 1.5 | 11.1 ± 1.7 | 10.6 ± 1.6 |
| Total gonadotropin dose (IU) | 2152.2 ± 681.3 | 3242.4 ± 1359.9 | 2483.9 ± 1065.5 |
| Sperm provider | |||
| Partner | 368 (87) | 161 (87) | 529 (87) |
| Donor | 55 (13) | 24 (13) | 79 (13) |
| Retrieved oocytes (n) | 23.9 ± 11.8 | 11.7 ± 6.0 | 20.2 ± 11.8 |
| MII oocytes injected (n) | 11.4 ± 2.8 | 9.3 ± 4.9 | 10.8 ± 3.7 |
| Fertilized oocytes (n) | 8.9 ± 2.6 | 7.0 ± 4.0 | 8.3 ± 3.2 |
| Fertilization rate (%) | 79.5 ± 14.3 | 78.1 ± 17.7 | 79.1 ± 15.4 |
| Blastocysts (n) | 6.2 ± 2.4 | 4.2 ± 2.8 | 5.6 ± 2.9 |
| Blastocyst rate (%) | 71.2 ± 20.9 | 59.8 ± 26.8 | 68.2 ± 23.2 |
| . | Oocyte donations (n = 423) . | Autologous PGT-A (n = 185) . | Total (n = 608) . |
|---|---|---|---|
| Culture strategy (%) | |||
| CS1 | 213 (50.4) | 0 (0) | 213 (35) |
| CS2 | 210 (49.6) | 185 (100) | 395 (65) |
| Oocyte provider age (years) | 25.5 ± 4.5 | 39.0 ± 3.4 | 29.6 ± 7.4 |
| Partner age (years) | 42.5 ± 6.4 | 40.4 ± 5.7 | 41.8 ± 6.3 |
| Oocyte provider BMI (kg/m2) | 22.6 ± 3.2 | 23.5 ± 3.8 | 22.9 ± 3.4 |
| Oocyte state | |||
| Fresh | 289 (68.3) | 181 (97.8) | 470 (77.3) |
| Vitrified | 134 (31.7) | 4 (2.2) | 138 (22.7) |
| Days of stimulation (days) | 10.3 ± 1.5 | 11.1 ± 1.7 | 10.6 ± 1.6 |
| Total gonadotropin dose (IU) | 2152.2 ± 681.3 | 3242.4 ± 1359.9 | 2483.9 ± 1065.5 |
| Sperm provider | |||
| Partner | 368 (87) | 161 (87) | 529 (87) |
| Donor | 55 (13) | 24 (13) | 79 (13) |
| Retrieved oocytes (n) | 23.9 ± 11.8 | 11.7 ± 6.0 | 20.2 ± 11.8 |
| MII oocytes injected (n) | 11.4 ± 2.8 | 9.3 ± 4.9 | 10.8 ± 3.7 |
| Fertilized oocytes (n) | 8.9 ± 2.6 | 7.0 ± 4.0 | 8.3 ± 3.2 |
| Fertilization rate (%) | 79.5 ± 14.3 | 78.1 ± 17.7 | 79.1 ± 15.4 |
| Blastocysts (n) | 6.2 ± 2.4 | 4.2 ± 2.8 | 5.6 ± 2.9 |
| Blastocyst rate (%) | 71.2 ± 20.9 | 59.8 ± 26.8 | 68.2 ± 23.2 |
CS1, culture strategy 1: Sanyo MCO-5M incubator and sequential culture media and Eeva Test 2.3; CS2, culture strategy 2: Geri+ and single-step culture medium and Eeva Test 3.0; MII: metaphase II oocyte; PGT-A: preimplantation genetic testing for aneuploidies.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
